International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was RUB 192.48 million compared to RUB 198.12 million a year ago. Net income was RUB 76.6 million compared to RUB 102.27 million a year ago.
International Medical Center of Biomaterials Processing and Cryostorage Public
Equities
GEMA
RU000A100GC7
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
672 RUB | -0.22% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 112M | |
+22.65% | 87.14B | |
-23.68% | 75.59B | |
+1.76% | 26.78B | |
+3.99% | 17.89B | |
-13.47% | 16.44B | |
+2.68% | 15.68B | |
+69.13% | 13.3B | |
+74.99% | 13.06B | |
+3.11% | 12.54B |
- Stock Market
- Equities
- GEMA Stock
- News International Medical Center of Biomaterials Processing and Cryostorage Public
- International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company Reports Earnings Results for the Nine Months Ended September 30, 2022